The FINANCIAL — Patrice Bula, Head of Strategic Business Units, Marketing, Sales and Nespresso, and a member of the Nestlé Group Executive Board, will take a well-deserved retirement at the end of February 2021. Patrice Bula has had a long and distinguished
More
The FINANCIAL — Nestle agreed to buy Aimmune Therapeutics Inc. for $2.6 billion, adding a promising peanut allergy treatment to its portfolio of coffee, snacks and water. The Swiss owner of Nespresso will pay $34.50 a share for the U.S. biotech firm, almost
More